This statement provides an update on the recommendations for use of pentavalent human-bovine reassortant rotavirus vaccine (RotaTeq®) and provides information on the safety, efficacy, and recommended use of live, attenuated monovalent human rotavirus vaccine (Rotarix™).
RotaTeq® : Update on RotaTeq®, Update on the safety of RotaTeq®, Update on the effectiveness of RotaTeq® (Merck Canada Inc.)
Rotarix™: Monovalent human rotavirus vaccine: Rotarix™, (GlaxoSmithKline Inc.)
Efficacy, Effectiveness, Vaccine safety and adverse events, Other Serious Adverse Events Following Immunization, Viral shedding and transmission, Concomitant administration of other childhood vaccines, Interchangeability, Dosage and Schedule, Contraindications, and Precautions.